Dr Iain R. J. Macpherson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The majority of effective systemic therapies in oncology are based on combinations of two or more drugs. The clinical benefits of combination over single-agent therapy may derive from enhanced cytotoxicity, abrogation of drug resistance or modulation of the tumour microenvironment. Previously, combinational oncology drug development focused on cytotoxic(More)
  • 1